Virpax Pharmaceuticals

Virpax Pharmaceuticals

Pharmaceuticals, 1055 Westlakes Dr, Berwyn, Pennsylvania, 19312, United States, 1-10 Employees

virpaxpharma.com

  • twitter
  • LinkedIn

Who is VIRPAX PHARMACEUTICALS

Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers lo...

Read More

map

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from VIRPAX PHARMACEUTICALS

Virpax Pharmaceuticals Org Chart and Mapping

Anthony Mack

Founding Chairman and CEO

Employees

Gerald Bruce

Executive Vice President of Commercial Operations, Board Director

Matt Barnes

Senior Director Portfolio Management

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Virpax Pharmaceuticals

Answer: Virpax Pharmaceuticals's headquarters are located at 1055 Westlakes Dr, Berwyn, Pennsylvania, 19312, United States

Answer: Virpax Pharmaceuticals's official website is https://virpaxpharma.com

Answer: Virpax Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: Virpax Pharmaceuticals's SIC: 2834

Answer: Virpax Pharmaceuticals has 1-10 employees

Answer: Virpax Pharmaceuticals is in Pharmaceuticals

Answer: Virpax Pharmaceuticals contact info: Phone number: Website: https://virpaxpharma.com

Answer: Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our dedication to addressing drug-resistant epilepsy and rare diseases. With a focus on optimizing non-addictive medications, our drug delivery platforms target unmet global needs in markets such as Post Operative Pain, Severe Pain, Post Cancer Pain, and Rare Pediatric Epilepsy, including orphan diseases like Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome. Virpax is at the forefront of providing differentiated solutions for these diverse healthcare challenges.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access